Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (61-70 of 385) with videos related to

Pageof 39
Sort By:
Journal of Neuro-Oncology|May 13, 2025
Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in GermanyDaniel Weidl, David Capper, Julia Onken, et al.
Blood|February 8, 2014
Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapyPatricia S Hähnel, Birgit Enders, Daniel Sasca, et al.
Haematologica|September 23, 2017
Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibitionJochen Greiner, Susanne Hofmann, Michael Schmitt, et al.
Blood|November 12, 2009
Quantitative DNA methylation predicts survival in adult acute myeloid leukemiaLars Bullinger, Mathias Ehrich, Konstanze Döhner, et al.
Blood|November 11, 2010
Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemiaKatja Fiedler, Anca Sindrilaru, Grzegorz Terszowski, et al.
The New England Journal of Medicine|April 16, 2004
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemiaLars Bullinger, Konstanze Döhner, Eric Bair, et al.
Haematologica|April 21, 2019
Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemiaEugen Tausch, William Close, Anna Dolnik, et al.
European Journal of Haematology|March 24, 2009
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemiaChristian Geisler, Jesper Jurlander, Lars Bullinger, et al.
Blood|May 5, 2012
Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expressionSylvie M Noordermeer, Davide Monteferrario, Mathijs A Sanders, et al.
International Journal of Molecular Sciences|March 25, 2022
Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival OutcomeElisa Ciraolo, Stefanie Althoff, Josefine Ruß, et al.
Pageof 39

Showing results (61-70 of 385) with videos related to

Sort By:
Pageof 39
Journal of Neuro-Oncology|May 13, 2025
Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in GermanyDaniel Weidl, David Capper, Julia Onken, et al.
Blood|February 8, 2014
Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapyPatricia S Hähnel, Birgit Enders, Daniel Sasca, et al.
Haematologica|September 23, 2017
Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibitionJochen Greiner, Susanne Hofmann, Michael Schmitt, et al.
Blood|November 12, 2009
Quantitative DNA methylation predicts survival in adult acute myeloid leukemiaLars Bullinger, Mathias Ehrich, Konstanze Döhner, et al.
Blood|November 11, 2010
Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemiaKatja Fiedler, Anca Sindrilaru, Grzegorz Terszowski, et al.
The New England Journal of Medicine|April 16, 2004
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemiaLars Bullinger, Konstanze Döhner, Eric Bair, et al.
Haematologica|April 21, 2019
Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemiaEugen Tausch, William Close, Anna Dolnik, et al.
European Journal of Haematology|March 24, 2009
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemiaChristian Geisler, Jesper Jurlander, Lars Bullinger, et al.
Blood|May 5, 2012
Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expressionSylvie M Noordermeer, Davide Monteferrario, Mathijs A Sanders, et al.
International Journal of Molecular Sciences|March 25, 2022
Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival OutcomeElisa Ciraolo, Stefanie Althoff, Josefine Ruß, et al.
Pageof 39